海思科：HSK47388片获准开展临床试验

Core Viewpoint - Company received approval from the National Medical Products Administration for clinical trials of HSK47388 tablets, intended for the treatment of autoimmune diseases [1] Company Summary - Company: 海思科 (002653.SZ) - Recent development: Approval for clinical trials of HSK47388 tablets [1] - Indication: Treatment for autoimmune diseases [1]